Skip to content

Clinical outcome of lateral elevation of the maxillary sinus supported by simultaneous implantation of NobelParallel CC implants

Single tooth reconstructions with lateral elevation of the maxillary sinus supported by simultaneous implantation of NobelParallel CC implants in posterior atrophic edentulous maxillae

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042169
Enrollment
Unknown
Registered
2021-01-14
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dentition Defect

Interventions

PCC implant with lateral elevation of the maxillary sinus:placement of PCC implant and treatment of lateral elevation of the maxillary sinus
PCC implant:only placement of PCC implant
other implant with lateral elevation of the maxillary sinus :placement of other implant and treatment of lateral elevation of the maxillary sinus
other implant :only placement of other implant

Sponsors

The Affiliated Hospital of Stomatology, School of Stomatology, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Informed consent was obtained; 2.Patients aged >=18 years; 3.Loss of single tooth in posterior maxillae (molar or premolar), in need for one implant; 4.There is vertical resorption at tooth loss site, and the vertical height of residual ridge is over 10 mm for the control group, while the vertical height of residual ridge is less than 6mm for atrophic group; 5.Patients receive treatment involving lateral elevation of the maxillary sinus in combination with the placement of NobelParallel CC implants in PCC group; while in control group, patients receive lateral elevation of the sinus as well as simultaneous implantation of implants of other brands. 6.Horizontal width of the residual bone at the edentulous site is over 6mm.

Exclusion criteria

Exclusion criteria: 1.General contraindications to implant surgery; 2.Subjected to irradiation in the head and neck area within two years prior to treatment; 3.Poor oral hygiene conditions (median of full mouth plaque index >= 2); 4.Uncontrolled diabetes (HbA1c > 8.0% or FBG > 150mg/dl); 5.Pregnant or nursing; 6.Psychiatric problems; 7.HIV infected patients; 8.Heavy smoking( > 20 cigarettes/day); 9.Benign or malignant tumors in the area intended for implant placement; 10.Treated or under treatment with intravenous amino-bisphosphonates; 11.Acute or chronic local inflammation including untreated periodontitis; 12.Extraction sites with less than 3 months of healing; 13.Severe bruxism or clenching habits; 14.Bone defect diseases such as osteoporosis.

Design outcomes

Primary

MeasureTime frame
marginal bone level;implants survival rate;prosthetics survival rate;implant stability quotient;peri-implant probing pocket depth;modified plaque index;gingival bleeding index;

Countries

China

Contacts

Public ContactHe Fuming

The Affiliated Hospital of Stomatology, School of Stomatology, Zhejiang University School of Medicine

hfm@zju.edu.cn+86 13516817697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026